Form 4 Tracker
Trevi Therapeutics, Inc.
TRVI

10 insider filings · Latest: Jun 3, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 7, 2025Oct 7 8:26 PMDelfini Lisa
Proposed Sale
108,650$9.50$1.0M

View →

Oct 3, 2025Oct 3 9:09 PMDelfini Lisa
Proposed Sale
40,000$9.67$386.7K

View →

Aug 27, 2025Aug 27 8:56 PMDelfini Lisa
Proposed Sale
312,855$8.09$2.5M

View →

Mar 21, 2025Mar 21 8:13 PMGOOD JENNIFER L
Proposed Sale
5,263$6.58$34.6K

View →

Mar 10, 2025Mar 10 8:32 PMSimon Farrell
Proposed Sale
81,313$6.75$548.9K

View →

Sep 3, 2024Sep 3 8:37 PMGOOD JENNIFER L
Proposed Sale
61,180$3.16$193.3K

View →

Aug 27, 2024Aug 27 8:10 PMMeeker David P
Proposed Sale
4,555$2.98$13.6K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 3, 2026Jun 4 8:28 PMEdward T MathersDirector
Grant/Award
35,000$13.4535,000(D)

View →

Jun 3, 2026Jun 4 8:05 PMDominick ColangeloDirector
Grant/Award
35,000$13.4535,000(D)

View →

Jun 3, 2026Jun 4 8:05 PMDavid P MeekerDirector
Grant/Award
35,000$13.4535,000(D)

View →

Jun 3, 2026Jun 4 8:05 PMAnne VanlentDirector
Grant/Award
35,000$13.4535,000(D)

View →

Jun 3, 2026Jun 4 8:05 PMMichael Thomas HeffernanDirector
Grant/Award
35,000$13.4535,000(D)

View →

Feb 19, 2026Feb 20 9:17 PMJames V CassellaChief Development Officer
Grant/Award
215,000$10.56215,000(D)

View →

Feb 19, 2026Feb 20 9:16 PMChristopher GallettaController and Principal Accounting Officer
Grant/Award
35,000$10.5635,000(D)

View →

Feb 19, 2026Feb 20 9:16 PMThomas SciasciaChief Scientific Officer
Grant/Award
85,000$10.5685,000(D)

View →

Feb 19, 2026Feb 20 9:16 PMJennifer L GoodDirector, President & CEO
Grant/Award
675,000$10.56675,000(D)

View →

Feb 19, 2026Feb 20 9:15 PMFarrell SimonChief Commercial Officer
Grant/Award
160,000$10.56160,000(D)

View →